WALTHAM, Mass.--(BUSINESS WIRE)--OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company will present at the UBS Global Life Sciences Conference at The Grand Hyatt Hotel in New York, New York on Thursday, September 27, 2007 at 4:00 pm EDT.
